Healthy Volunteers

Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers as a Single Agent or in Combination With Plerixafor

Condition:   Healthy Volunteers
Interventions:   Biological: MGTA-145;   Biological: plerixafor;   Biological: Placebo
Sponsor:   Magenta Therapeutics, Inc.
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 1, 2019Comments OffAgent | Assessing | Combination | Healthy | MGTA145 | Pharmacodynamics | Pharmacokinetics | Plerixafor | Safety | Single | Study | Tolerability | Volunteers
Evaluation of the Healthy Lifestyle Program on Cognitive Outcomes

Condition:   Obesity
Intervention:   Behavioral: Evaluate Healthy Lifestyle Program on cognitive outcomes
Sponsor:   Dartmouth-Hitchcock Medical Center
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 30, 2019Comments OffCognitive | Evaluation | Healthy | Lifestyle | Outcomes | Program
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending, Subcutaneous, Single and Multiple Doses of SHP681 (Glucagon-like Peptide-2 [GLP-2] Analog-Fc Fusion) in Healthy Adult Participants

Condition:   Healthy Volunteers
Interventions:   Drug: SHP681;   Drug: Placebo
Sponsor:   Shire
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 29, 2019Comments OffAdult | AnalogFc | Ascending | Assess | Doses | Fusion | GLP2 | Glucagonlike | Healthy | Multiple | Participants | Peptide2 | Pharmacokinetics | Safety | SHP681 | Single | Study | Subcutaneous | Tolerability
Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.

Condition:   Idiopathic Pulmonary Fibrosis
Intervention:   Drug: Epigallocatechin-3-gallate (EGCG)
Sponsors:   University of California, San Francisco;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 28, 2019Comments OffFibroblast | Fibrosis | Inhibition | LOXL2 | Patients | Pulmonary | Signaling | Specific | TGFbeta1
Physiological Validation of Current Machine Learning Models for Hemodynamic Instability in Humans

Condition:   Hypotension and Shock
Intervention:   Other: Assigned Interventions
Sponsor:   Mayo Clinic
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 27, 2019Comments OffCurrent | Hemodynamic | Humans | Instability/ | Learning | Machine | Models | Physiological | Validation
Effects of Vitamin B3 Derivative Nicotinamide Riboside (NR) in Bone, Skeletal Muscle and Metabolic Functions in Aging

Condition:   Healthy Elderly Volunteers
Interventions:   Dietary Supplement: Nicotinamide Riboside;   Dietary Supplement: Placebo
Sponsor:   Mayo Clinic
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 26, 2019Comments OffAging | Bone | Derivative | Effects | Functions | Metabolic | Muscle | Nicotinamide | Riboside | Skeletal | Vitamin
GSNOR Phenotyping/GSNO Challenge

Conditions:   Asthma;   Healthy Volunteers
Intervention:   Drug: GSNO
Sponsors:   James Reynolds;   University Hospitals Cleveland Medical Center;   Case Western Reserve University;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 25, 2019Comments OffChallenge | GSNOR | Phenotyping/GSNO
The Weaving Healthy Families Program to Promote Wellness and Resilience and Prevent Alcohol and Other Drug Abuse and Violence

Conditions:   Alcohol Abuse;   Drug Use;   Violence, Domestic;   Child Abuse;   Diet Modification;   Health Behavior;   Health Knowledge, Attitudes, Practice;   Relationship, Family;   Relation, Parent-Child;   Emotional Stress
Intervention:   Behavioral: Weaving Healthy Families Program
Sponsors:   Tulane University;   National Institutes of Health (NIH)
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 24, 2019Comments OffAbuse | Alcohol | Drug | Families | Healthy | Prevent | Program | Promote | Resilience | Violence | Weaving | Wellness
A Home-based Intervention to Improve the Diet Quality of Preschoolers

Condition:   Diet Modification
Interventions:   Behavioral: Healthy Feeding, Healthy Eating;   Behavioral: Reading Readiness
Sponsors:   University of Rhode Island;   Brown University;   University of Connecticut
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 23, 2019Comments OffDiet | HomeBased | Improve | Intervention | Preschoolers | Quality
A Safety, Tolerability, and Pharmacokinetic Study of Tucatinib in Healthy Japanese and Caucasian Subjects

Condition:   Healthy
Intervention:   Drug: Tucatinib
Sponsor:   Seattle Genetics, Inc.
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 22, 2019Comments OffCaucasian | Healthy | Japanese | Pharmacokinetic | Safety | Study | Subjects | Tolerability | Tucatinib